Gene | ERBB2 |
Variant | CNV |
Transcript ID (GRCh37/hg19) | ENST00000269571 |
Germline/Somatic? | Somatic |
Tumor Type | Primary Site |
---|
In breast cancer, ERBB2 (HER2) amplification and over-expression are associated with sensitivity to anti-HER2 agents, such as Trastuzumab. Drug : Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-trastuzumab emtansine, Lapatinib, Trastuzumab,
This gene is a known cancer gene.